Product NDC: | 0409-1120 |
Proprietary Name: | Ondansetron |
Non Proprietary Name: | ONDANSETRON HYDROCHLORIDE |
Active Ingredient(s): | 2 mg/mL & nbsp; ONDANSETRON HYDROCHLORIDE |
Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0409-1120 |
Labeler Name: | Hospira, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA077840 |
Marketing Category: | ANDA |
Start Marketing Date: | 20070119 |
Package NDC: | 0409-1120-12 |
Package Description: | 10 SYRINGE in 1 CARTON (0409-1120-12) > 2 mL in 1 SYRINGE |
NDC Code | 0409-1120-12 |
Proprietary Name | Ondansetron |
Package Description | 10 SYRINGE in 1 CARTON (0409-1120-12) > 2 mL in 1 SYRINGE |
Product NDC | 0409-1120 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | ONDANSETRON HYDROCHLORIDE |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRAMUSCULAR; INTRAVENOUS |
Start Marketing Date | 20070119 |
Marketing Category Name | ANDA |
Labeler Name | Hospira, Inc. |
Substance Name | ONDANSETRON HYDROCHLORIDE |
Strength Number | 2 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Serotonin 3 Receptor Antagonists [MoA],Serotonin-3 Receptor Antagonist [EPC] |